ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 95 | ESPE2022 | Next issue

60th Annual ESPE (ESPE 2022)

Rome, Italy
15 Sept 2022 - 17 Sept 2022

Card image cap
The 60th ESPE Annual Meeting will now be taking place in Rome, Italy.

Poster Category 1

Adrenals and HPA Axis

Table of contents
Next section
Bone, Growth Plate and Mineral Metabolism

hrp0095p1-1 | Adrenals and HPA Axis

Collection of salivary steroids in children under conditions replicating home sampling

hrp0095p1-2 | Adrenals and HPA Axis

Growth evaluation by applying the QEPS growth model in patients with CAH

hrp0095p1-3 | Adrenals and HPA Axis

Blood pressure (BP) status in Congenital Adrenal Hyperplasia (CAH) – longitudinal analysis of real world data from the I-CAH registry

hrp0095p1-4 | Adrenals and HPA Axis

Glucocorticoid-induced adrenal insufficiency: morning plasma cortisol values safely assess recovery of the HPA axis in pediatrics

hrp0095p1-5 | Adrenals and HPA Axis

Urinary steroid metabolite ratios: sex- and age-dependent changes and use for the differential diagnosis of inborn steroidogenesis disorders

hrp0095p1-6 | Adrenals and HPA Axis

Clinical and Genetic characterization of primary adrenal insufficiency in Sudanese children

hrp0095p1-7 | Adrenals and HPA Axis

Management of mineralocorticoid deficiency in Congenital Adrenal Hyperplasia – a single centre study

hrp0095p1-8 | Adrenals and HPA Axis

Evolution of the Short Synacthen Test over a decade - a single UK centre’s experience

hrp0095p1-9 | Adrenals and HPA Axis

Identification of a novel CYP11B2 variant in a family with varying degrees of aldosterone synthase deficiency

hrp0095p1-10 | Adrenals and HPA Axis

Outcomes of the low dose short Synacthen test in infancy

hrp0095p1-11 | Adrenals and HPA Axis

Low-dose ACTH Stimulation Test: Comparison of Cortisol Response at 30, 40, and 60 Minutes

hrp0095p1-12 | Adrenals and HPA Axis

Novel Homozygous Mutation in a Boy with Pseudohypoaldosteronism Type 1

hrp0095p1-13 | Adrenals and HPA Axis

Clinical characteristics and pubertal development in Greek girls with premature adrenarche.

hrp0095p1-14 | Adrenals and HPA Axis

Demographic, Clinical, Hormonal And Genetic Characteristics Of Children And Adolescents With Congenital Adrenal Hyperplasia Due To 11-Beta Hydroxylase Deficiency

hrp0095p1-15 | Adrenals and HPA Axis

Growth from Birth to Adult Height in Patients with Classical Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: A Collaborative Study

hrp0095p1-16 | Adrenals and HPA Axis

Long-term follow-up of three male siblings with a novel NNT pathogenic variant causing primary adrenal insufficiency

hrp0095p1-17 | Adrenals and HPA Axis

Expanding the phenotype of deglycosylation disorders: Adrenal Insufficiency and Micropenis in NGLY1-CDDG

hrp0095p1-18 | Adrenals and HPA Axis

Very early and atypical presentation of Triple A (Allgrove) syndrome

hrp0095p1-201 | Adrenals and HPA Axis

Gene Chimeras Involving CYP21A2 and TNXB Genes in Spanish Patients with Congenital Adrenal Hyperplasia (CAH)

hrp0095p1-202 | Adrenals and HPA Axis

Abstract unavailable

hrp0095p1-203 | Adrenals and HPA Axis

P450 oxireductase (POR) regulates blood brain (BBB) maturation by mediating retinoic acid (RA) metabolism in a model of the human BBB

hrp0095p1-204 | Adrenals and HPA Axis

Reduced cognitive function in children with classical 21-hydroxylase deficient congenital adrenal hyperplasia (21OHD-CAH).

hrp0095p1-205 | Adrenals and HPA Axis

Exploring the growth curves of 248 Chinese patients aged 0-3 years with salt-wasting 21-hydroxylase deficiency

hrp0095p1-206 | Adrenals and HPA Axis

Primary adrenal insufficiency in a patient with biallelic QRSL1 mutations

hrp0095p1-207 | Adrenals and HPA Axis

Clinical and genetic characteristics of androgen insensitivity syndrome

hrp0095p1-208 | Adrenals and HPA Axis

Targeting melanocortin type 2 receptor (MC2R) with peptides for the treatment of congenital adrenal hyperplasia

hrp0095p1-209 | Adrenals and HPA Axis

Systematic review of cortisol levels during acute illnesses in children and young people not known to have glucocorticoid deficiency

hrp0095p1-210 | Adrenals and HPA Axis

Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency: the correlation of 17-hydroxyprogesterone stimulated concentrations with genotype for the identification of the molecular defect- A study of 526 cases

hrp0095p1-211 | Adrenals and HPA Axis

Effect of maternal steroid medication prescribed during pregnancy on neonatal adrenal function

hrp0095p1-212 | Adrenals and HPA Axis

Molecular Analyses of A Virilized Newborn. Implications in Clinical Management

hrp0095p1-213 | Adrenals and HPA Axis

Alterations in glucocorticoid metabolism as a possible cause of hypertension in childhood obesity

hrp0095p1-214 | Adrenals and HPA Axis

Development and validation of simultaneous quantification of urinary catecholamines and free metanephrines by UHPLC-MS/MS method

hrp0095p1-215 | Adrenals and HPA Axis

Salt-Wasting CAH phenotype as a result of the TNXA/TNXB Chimera 1 (CAH-X CH-1) and the severe IVS2-13A/C>G in CYP21A2 gene

hrp0095p1-216 | Adrenals and HPA Axis

Salivary Cortisol in Children with Congenital Adrenal Hyperplasia and Different Treatment Regimens

hrp0095p1-217 | Adrenals and HPA Axis

Precocious Pubarche in Girls - A Clinical Sign for Underlying Hyperandrogenic Disease

hrp0095p1-401 | Adrenals and HPA Axis

Increased Basal Levels of 17-Hydroxyprogesterone In The Covid ERA: Must We Change The Cut-Off Point To Request Acth Test?

hrp0095p1-402 | Adrenals and HPA Axis

Glucose regulation and cardiovascular health in children and young people with primary adrenal insufficiency

hrp0095p1-403 | Adrenals and HPA Axis

Outcomes of treatment in pediatric Cushing`s disease

hrp0095p1-404 | Adrenals and HPA Axis

Steroid metabotyping in treated infants with classical congenital adrenal hyperplasia by chromatography-mass spectrometry analysis

hrp0095p1-405 | Adrenals and HPA Axis

Body composition in children and adolescents with non-classic congenital adrenal hyperplasia and risk for metabolic syndrome components – an observational study

hrp0095p1-406 | Adrenals and HPA Axis

Salt-wasting in newborns due to adrenal dysfunctions other than 21 OH Congenital adrenal hyperplasia (CAH) : a single center experience

hrp0095p1-407 | Adrenals and HPA Axis

Agreement between Acth-low test and Insuline Tolerance Test in Patients with Risk Factors for Central Adrenal Insufficiency

hrp0095p1-408 | Adrenals and HPA Axis

Diverse clinical features, genetic etiologies, and histopathological features of adrenal neoplasms in children and adolescents

hrp0095p1-409 | Adrenals and HPA Axis

Clinical, laboratory and body composition profile of young female patients with non-classic congenital adrenal hyperplasia

hrp0095p1-410 | Adrenals and HPA Axis

Neonatal Screening for Congenital Adrenal Hyperplasia in Saudi Arabia: A Retrospective, Descriptive study

hrp0095p1-411 | Adrenals and HPA Axis

Prevalence and Incidence of Congenital Adrenal Hyperplasia in Denmark – a nationwide cohort study

hrp0095p1-412 | Adrenals and HPA Axis

A single centre experience of aromatase inhibitors to limit bone age advancement in pre-pubertal boys with adrenal disorders causing androgen excess

hrp0095p1-413 | Adrenals and HPA Axis

Incidence and severity of Coronavirus Disease 2019 (COVID-19) in children with primary and secondary adrenal insufficiency during the pandemic in Italy

hrp0095p1-414 | Adrenals and HPA Axis

A short intragenic inversion in CYP11B1 gene involved in a 46,XX virilizing congenital adrenal hyperplasia: interest of cross-use of targeted massively parallel and Sanger sequencing.

hrp0095p1-415 | Adrenals and HPA Axis

Basal cortisol measurements in the prediction of low-dose ACTH stimulation test outcomes

hrp0095p1-416 | Adrenals and HPA Axis

The assessment of the usefulness of morning cortisol and DHEAS concentration levels in the diagnosis of central adrenal insufficiency in pediatric patients - preliminary results

hrp0095p1-417 | Adrenals and HPA Axis

A patient with autoimmune polyglandular syndrome type 1 with atypical presentation

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more